GeoPharma, Inc.

(NASDAQ:GORX)

Key Stats & Ratios

Valuation
Market Cap 12.63M
P/E
P/E (Trailing)
P/E (Forward)
Price/Sales 0.19
Price/Book 0.52
EPS -0.75
EPS Growth (ttm) -100.00%
Fiscal Year
Fiscal Year Ends Mar 31
Last Quarter Jun 2008
Profitability
Operating Income -12452328.00
Net Income -10642968.00
Profit Margin (ttm) -13.60%
Operating Margin (ttm) -0.15%
Management Effectiveness
Return on Assets (ttm) -15.20%
Return on Equity (ttm)
EBIT Margin (ttm) -15.90
SEC Filings
Latest Form 10-Q (Quartely)
Latest Form 10-K (Annual)

Financials

Income Statement
Total Enterprise Value 35.31M
Revenue 78.19M
Revenue/Share 4.58
Revenue Growth (ytd) 180.90%
Annual Revenue Growth Rate (3Y) 14.10%
Annual Income Growth Rate (3Y)
Earnings Growth (ytd)
Gross Operating Profit (ttm) 15.82M
EBITDA -8801417.00
Diluted EPS (ttm) -0.75
Balance Sheet
Total Cash 1.37M
Total Cash/Share 0.08
Total Assets 70.02M
Total Liabilities 41.08M
Total Debt/Equity
Long Term Debt Common Equity Ratio 0.57
Current Ratio 1.00
Leverage Ratio 2.00
Book Value/Share 1.70
Cash Flow
Cash Flow -7329557.00
Free Cash Flow -4462856.00
Cash Flow/Share -0.44
Free Cash Flow/Share -0.27

Trading Information

Stock Price History
Beta 1.02
52Wk Change -73.40%
52Wk Change Vs. Mkt -60.00%
52Wk High 3.32
52Wk Low 0.25
10 Day Moving Average 0.58
200 Day Moving Average 1.79
Share Statistics
Average Volume 28.80K
Shares Outstanding 17.07M
Shares Float 10.13M
% Held by Insiders 40.70%
% Held by Institutions 7.80%
Shares Short (As of Dec 10, 2008) 65.87K
Short Ratio 1.90
Short % of Float 0.70%
Dividends & Splits
Dividend Date
Dividend Yield
Dividend Amount